1 / 28

Preeclampsia - Eclampsia

Preeclampsia - Eclampsia. Jack Ludmir, M.D. 2010. Maternal Mortality in the World. 600,000 per year due to pregnancy-related causes. Maternal Mortality. USA: 15/100,000 live births Mali: 800/100,000 live births Hemorrhage Embolism Preeclampsia Infection.

oshin
Télécharger la présentation

Preeclampsia - Eclampsia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Preeclampsia - Eclampsia Jack Ludmir, M.D. 2010

  2. Maternal Mortality in the World 600,000 per year due to pregnancy-related causes

  3. Maternal Mortality • USA: 15/100,000 live births • Mali: 800/100,000 live births • Hemorrhage • Embolism • Preeclampsia • Infection

  4. Autopsy Specimen from a 40-Year-Old Woman with Severe Preeclampsia and Subarachnoid Hemorrhage Greene M. N Engl J Med 2003;348:275-276

  5. 2200 BC Egypt: pregnant women with fists 400 BC Hippocrates: pregnant women with convulsions Eclampsia: Greek word: suddenly, flash 1619: Varardus: first use of word eclampsia 1843: Lever. Proteinuria. Swelling and convulsions: Nephritic toxemia 1897: Vaquez. Hypertension 1899: Strogonov: treatment, sedation 1900s: prenatal care, preeclampsia New concept in the 20th century 1902: Ballantyne. Pro-maternity clinic. 1910: USA. Nursing visits at home. 1920: Prenatal visits: check for hypertension, swelling, proteinuria to detect : Preeclampsia Maternal mortality reduced in UK from 319/100,000 in 1936 to 15/100,000 in 1985 PRE: History Eclampsia - Preeclampsia Prenatal Care

  6. Hypertensive Disorders of Pregnancy Sibai B. N Engl J Med 1996;335:257-265

  7. Conditions Sometimes Confused with Preeclampsia or Eclampsia Sibai B. N Engl J Med 1996;335:257-265

  8. Preeclampsia - Eclampsia • Hypertension after 20 weeks gestation • Proteinuria > than 300 mg/dl or +1 dipstick • Convulsions: eclampsia

  9. Preeclampsia • Incidence: 5 - 8% of all pregnancies. • Etiology remains elusive. • Major cause for maternal and perinatal mortality and morbidity. • To date no treatment for prevention (baby ASA or calcium) or cure, except delivery. • However, the maternal benefits must be weighed against the neonatal risks of preterm delivery.

  10. Etiology • Multiple theories: toxins, nephritis, parasites, malnutrition, vitamin deficiency, immunologic, inflammation, oxidation, prostaglandin imbalance, angiogenic factors,……..

  11. Pathophysiology • Endothelial cell injury • Generalized vasoconstriction

  12. Implantation Rogers et al: Obst Gynecol Survey 54:189,1999

  13. Atherosis in placental bed Rogers et al: Obst Gynecol Survey 54:189,1999

  14. Renal-Biopsy Specimen Showing Glomerulus with Reactive Endothelial Cells That Narrow Capillary Lumens (Arrowheads) and Duplicated Glomerular Basement Membrane (Arrows) (Periodic Acid-Schiff, x450) Ludmir J and Smith R. N Engl J Med 1998;339:906-913

  15. Possible mechanisms in Preeclampsia Friedman and Lindheimer,1999

  16. Preeclampsia - Pathophysiology • May be initiated by placental factors that enter the maternal circulation and cause endothelial dysfunction resulting in hypertension and proteinuria. • Recently, soluble fms-like tyrosine kinase 1 (sFlt-1) an antiangiogenic protein has been found to be increased in preeclampsia (Maynard et al.J Clin Invest 2003)

  17. + VEGF + PIGF - sFlt1 Angiogenic Factors Endothelium

  18. Preeclampsia - Pathophysiology • sFlt-1 acts by binding to placental growth factor(PGF) and vascular endothelial growth factor (VEGF), preventing the interaction with endothelial receptors on the cell surface and inducing endothelial dysfuntion. • Exogenous administration of sFlt-1 in pregnant rats induces hypertension, proteinuria, and glomerular endotheliosis.

  19. Circulating Angiogenic Factors and the Risk of Preeclampsia Levine et al. NEJM 2004

  20. Circulating angiogenic factors Increased levels of sFlt-1 and reduced levels of PIGF predict the subsequent development of preeclampsia Levine et al. NEJM 2004

  21. Preeclampsia - Pathophysiology • Soluble Endoglin (CD105), a cell receptor for transforming growth factor-beta (TGF-β), has been localized to both placental syncytiotrophoblasts and endothelial cells. • The primary role include angiogenesis, endothelial cell differentiation and regulation of vascular tone through endothelial nitric oxide synthetase (enos)

  22. Preeclampsia - Pathophysiology • Soluble endoglin as a second trimester marker for preeclampsia • Soluble endoglin elevated in patients destined to develop severe early-onset preeclampsia Robinson JC, Johnson D. AJOG 2007:197

  23. Circulating angiogenic factors Increase sFlt-1 Increase Endoglin Decrease PGIF in patients that will develop clinical preeclampsia Levine et al, NEJM; 2004 Robinson CJ, Johnson DD. AJOG 2007

  24. Preeclampsia: Management • Mild: 140/90, +1 proteinuria. Management: conservative, bedrest, deliver if close to term • Severe: Significant HTN, proteinuria (>5g/24hrs) or any systemic manifestation of the disease. Management: Consider delivery • Eclampsia: Delivery

  25. Severe Preeclampsia Criteria In order to make the diagnosis, one of the following should be present: • Blood pressure of 160 mm Hg systolic or higher or 110 mm Hg diastolic or higher on two occasions at least 6 hours apart while the patient is on bed rest • Proteinuria of 5 g or higher in a 24-hour urine specimen or 3+ or greater on two random urine samples collected at least 4 hours apart • Oliguria of less than 500 mL in 24 hours • Cerebral or visual disturbances • Pulmonary edema or cyanosis • Epigastric or right upper-quadrant pain • Impaired liver function • Thrombocytopenia • Fetal growth restriction ACOG,Practice Bull.2002

  26. Hauth (2000) Buchbinder (2002) Hnat (2002) Mild (n=217) Severe (n=109) Mild (n=62) Severe (n=45) Mild (n=86) Severe (n=70) <35wks (%) 1.9 18.5 4.8 11.4 2.3 18.6 SGA (%) 10.2 18.5 4.8 11.4 NR NR Abruption (%) 0.5 3.7 3.2 6.7 0 1.4 Perinatal mortality (%) 1.0 1.8 0 8.9 0 1.4 Severe Preeclampsia: Mild v. Severe

  27. Severe PIH Remote from Term - Concerns • Prompt delivery is curative and avoids possible bad consequences to mom and baby. (abruption, seizures…) • Prompt delivery may cause significant morbidity or mortality to baby due to prematurity

  28. Severe preeclampsia remote from term: concerns Maternal risks Fetal risks

More Related